Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Principal Investigator
Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash.
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
A single-molecule platform for investigation of interactions between G-quadruplexes and small-molecule ligands.
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development. Clin Gastroenterol Hepatol. 2019 08; 17(9):1673-1679.e1.
View in:
PubMed
subject areas
Clinical Trials as Topic
Colitis, Ulcerative
European Union
Government Agencies
Guidelines as Topic
Humans
Intestinal Mucosa
Patient Reported Outcome Measures
Treatment Outcome
United States
United States Food and Drug Administration
authors with profiles
David Rubin